Real-World Data: FDA Expounds On Use Of Registries, Challenges In Standardization

 
• By Brenda Sandburg

Final guidance on assessing registries notes responsibility of sponsors to ensure reliability of data from other organizations and reduce loss of participants to follow-up, while final guidance on data standards for RWD acknowledges sponsors may have limited access to a study’s data sources.

Real World
FDA issues two final guidances on use of real-world data to generate real-world evidence for drugs and biologics • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials